Methotrexate (Folitrax (10 mg) ) is an antimetabolite, curative in choriocarcinoma (cancer of the tissue that normally would develop into placenta). It is also used in other cancers like blood, breast ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Please provide your email address to receive an email when new articles are posted on . Combination therapy with methotrexate and pegloticase was more impactful at resolving gout symptoms than ...

Charlotte, NC and Mobile, AL - The new antifolate CH-1504 (Chelsea Therapeutics, Charlotte, NC), formerly known as MobileTrex or M-Trex, does not give rise to the polyglutamated and hydroxylated ...

The findings add complexity to questions about the long-term impact of acute lymphoblastic leukemia (ALL) therapy. A new report shows high cumulative doses of intravenous methotrexate can have ...

The use of low-dose methotrexate among older adults with chronic kidney disease (CKD) was associated with a significantly increased risk at 90 days for serious adverse events requiring a hospital ...

Please provide your email address to receive an email when new articles are posted on . “The disease-modifying anti-rheumatic drug methotrexate is the standard-of-care treatment of inflammatory ...

plaque psoriasis The efficacy, safety, pharmacokinetics, and immunogenicity of adalimumab combined with MTX compared with that adalimumab in patients with chronic plaque psoriasis is evaluated. Adding ...

Oct. 28 -- MONDAY, Oct. 27 (HealthDay News) -- The drugs etanercept and methotrexate are safe and effective for long-term, continuous treatment of juvenile rheumatoid arthritis, new research finds. In ...

Methotrexate, a folate antagonist which reversibly inhibits the enzyme dihydrofolate reductase, limits the availability of one-carbon fragments necessary for the synthesis of purines which interferes ...

The MarketWatch News Department was not involved in the creation of this content. MONTREAL, March 15, 2024 /CNW/ - Pharmascience Canada is proud to announce the launch of pms- METHOTREXATE INJECTION ...